Kimberly Luddy
@kimberly-luddy.bsky.social
š¤ 608
š„ 408
š 20
Theoretical and experimental immunologist working in cancer research. Moffitt Cancer Center
reposted by
Kimberly Luddy
British Society for Immunology
6 days ago
Master complex multiparameter flow cytometry with confidence! Join our course led by trainer Derek Davies & learn how to design robust experiments, troubleshoot issues & generate reliable data using real immunology examples. 11 & 18 May, Register now:
https://bit.ly/4qip05l
0
4
1
reposted by
Kimberly Luddy
British Society for Immunology
18 days ago
𧬠Have you submitted your abstract for
#UKimmunomet26
? The deadline is approaching in 3 weeks! Join the UKās leading immunometabolism meeting in NCL for cutting edge research, international speakers & sessions for ECRs. Find out more & register š
https://bit.ly/493uE45
0
3
5
reposted by
Kimberly Luddy
Nature Reviews Cancer
20 days ago
š„³ Our 5th most downloaded
#REVIEW
in 2025: Cross-priming in cancer immunology and immunotherapy
#TME
#immunotherapy
@NatResCancer
#NRCtop10of2025
loading . . .
Cross-priming in cancer immunology and immunotherapy - Nature Reviews Cancer
In this Review, Luri-Rey et al. present evidence for the crucial role of conventional type 1 dendritic cells in cross-presenting antigens from other cells via the major histocompatibility complex class I antigen-presenting machinery, which in turn is necessary to prime CD8+ T cells, which then mount efficient immune responses against cancer. The authors also discuss how we can exploit these processes in cancer immunotherapy by increasing the number and/or maturation or activation status of this specialist subtype of antigen-presenting cell.
http://dlvr.it/TQs3d0
0
3
6
reposted by
Kimberly Luddy
Nature Reviews Cancer
about 1 month ago
loading . . .
Tumour explants as next-generation models of cancer
Nature Reviews Cancer, Published online: 20 January 2026; doi:10.1038/s41568-026-00907-1To preserve tumour architecture, cellular heterogeneity and the dynamic crosstalk that influences cancer, Fong and colleagues advocate for coordinated, cross-disciplinary and sustained efforts to promote the widespread adoption of tumour explants.
http://dlvr.it/TQSZdg
0
3
2
reposted by
Kimberly Luddy
Waggoner Lab
2 months ago
Leukemia-driven expansion of ILC3 facilitates a pro-tumoral microenvironment in acute myeloid leukemia
#AML
@ohiostatemed.bsky.social
www.nature.com/articles/s41...
0
4
2
reposted by
Kimberly Luddy
Waggoner Lab
3 months ago
Double stranded RNA sensing is silenced during early embryonic development
@natcomms.nature.com
@edinburghup.bsky.social
www.nature.com/articles/s41...
0
6
4
NSD2 targeting reverses plasticity and drug resistance in prostate cancer
www.nature.com/articles/s41...
loading . . .
NSD2 targeting reverses plasticity and drug resistance in prostate cancer - Nature
Inhibition of the histone methyltransferase NSD2 and the androgen receptor in preclinical models can reverse lineage plasticity to suppress tumour growth and promote cell death in multiple subtypes of...
https://www.nature.com/articles/s41586-025-09727-z
3 months ago
0
0
0
reposted by
Kimberly Luddy
Itai Yanai
3 months ago
Thereās an art to writing a grant proposal so that your creativity is on full display. Maria Leptin - president of the ERC - talks about it on the new episode of the Night Science Podcast.
2
45
12
reposted by
Kimberly Luddy
Bryan Bryson
3 months ago
The
@ragoninstitute.bsky.social
is launching a new faculty search for a computational immunologist! Applications are open now and reviewed on a rolling basis. Please share broadly with your networks!
#immunosky
www.nature.com/naturecareer...
loading . . .
Computational Immunologist - Boston, Massachusetts (US) job with Ragon Institute of MGH, MIT, & Harvard | 12849577
The Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard in Cambridge MA, together with the Departmen
https://www.nature.com/naturecareers/job/12849577/computational-immunologist/
0
16
20
reposted by
Kimberly Luddy
Ben Hall
3 months ago
Very excited to announce that MSc computational cancer is now open for applications! A new joint programme from UCL engineering & cancer institute. Teaching
#cancer
through a computational lens, integrating cutting edge research with taught components. Apply below!
www.ucl.ac.uk/prospective-...
loading . . .
Computational Cancer MSc
Be part of the revolution in cancer research and computational science with this interdisciplinary Masterās at UCL. Delivered jointly by UCL Medical Physics and Biomedical Engineering and the UCL Cancer Institute, this programme equips you with cutting-edge skills at the forefront of healthcare innovation.
https://www.ucl.ac.uk/prospective-students/graduate/taught-degrees/computational-cancer-msc
0
4
4
reposted by
Kimberly Luddy
I-75 Scientist
3 months ago
Updates to the submission process for LOIs and grants requesting more than $500K in any budget periods.
grants.nih.gov/grants/guide...
loading . . .
NOT-OD-26-019: Updated Application Policies: NIH Administrative Burden Reduction Effort Removal of Requirements for Letters of Intent and Unsolicited Applications Requesting $500,000 or More in Dire...
NIH Funding Opportunities and Notices in the NIH Guide for Grants and Contracts: Updated Application Policies: NIH Administrative Burden Reduction Effort Removal of Requirements for Letters of Inten...
https://grants.nih.gov/grants/guide/notice-files/NOT-OD-26-019.html
1
7
9
reposted by
Kimberly Luddy
Richard Sever
3 months ago
UKRI exploring use of AI in grant review - this will prompt debate but interested to know if people think itād encourage novelty or the opposite?
www.chemistryworld.com/news/ukri-op...
loading . . .
UKRI opens up grant proposal data to explore using AI to smooth peer review
Surging applications has led the UK's main funder to look at ways to reduce the burden on reviewers
https://www.chemistryworld.com/news/ukri-opens-up-grant-proposal-data-to-explore-using-ai-to-smooth-peer-review/4022597.article
18
5
27
reposted by
Kimberly Luddy
Itai Yanai
7 months ago
The creative process in science has a set of thinking tools that we could do a better job teaching. Here are the 12 articles that Martin and I wrote about them, including "It takes two to think", "A hypothesis is a liability" and "The two languages of science".
night-science.org/home/learn/r...
4
111
27
The DNA replication checkpoint targets the kinetochore to reposition DNA structure-induced replication damage to the nuclear periphery
www.cell.com/cell-reports...
loading . . .
The DNA replication checkpoint targets the kinetochore to reposition DNA structure-induced replication damage to the nuclear periphery
Expanded CAG repeats, the cause of Huntingtonās disease, stall replication and reposition to the nuclear periphery to effect repair. Maclay et al. report that the DNA replication checkpoint targets th...
https://www.cell.com/cell-reports/fulltext/S2211-1247(25)00854-X?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS221112472500854X%3Fshowall%3Dtrue
7 months ago
0
1
0
reposted by
Kimberly Luddy
Jie Yang
8 months ago
We're recruiting a postdoc to join my lab at
@oncology.ox.ac.uk
&
@oxcio.bsky.social
to understand immune regulation in cancer and develop new approaches for cancer prevention and metastasis. Deadline: 11 August 2025
my.corehr.com/pls/uoxrecru...
Lab info:
www.oncology.ox.ac.uk/team/jie-yang
loading . . .
Job Details
https://my.corehr.com/pls/uoxrecruit/erq_jobspec_version_4.display_form?p_company=10&p_refresh_search=Y&p_display_in_irish=N&p_process_type=&p_form_profile_detail=&p_applicant_no=&p_internal_external=E&p_recruitment_id=180940&p_display_apply_ind=Y
0
5
11
reposted by
Kimberly Luddy
Paul Macklin
7 months ago
Nice writeup of our new
@cp-cell.bsky.social
article on an intuitive, plain language "grammar" to make simulation modeling of complex multicellular systems more accessible. Huge thx to Forest Ray and
@genomeweb.bsky.social
! Joint work by
@fertiglab.bsky.social
, Genevieve Stein-O'Brien & team! š§Ŗ
add a skeleton here at some point
1
10
3
reposted by
Kimberly Luddy
Waggoner Lab
7 months ago
Differentiation-associated ISG expression of NK cells in chronic viral infection
@cp-iscience.bsky.social
www.cell.com/iscience/ful...
1
5
2
reposted by
Kimberly Luddy
Waggoner Lab
7 months ago
Review of the possible role of Matzinger's "danger theory" of damage-associated molecular patterns in CNS as drivers of increased incidence of major depressive disorder
www.science.org/doi/10.1126/...
0
11
9
reposted by
Kimberly Luddy
Chrystal Paulos
7 months ago
š§µ1/ New in @Cancer_Cell: Our lab discovered that Th17 cells must team up with B cells to eliminate tumors, and prevent it from coming back. š Read:
www.cell.com/cancer-cell/...
š§¬This unexpected immune duo sparks tumor immunity. š¼ļøImage: See schematic Th17/B cell antitumor action!
loading . . .
Adoptively transferred Th17 cells cooperate with host B cells to achieve durable tumor immunity
Cole et al. report that adoptively transferred, tumor-specific Th17 cells engage host B cells and drive B cell proliferation and differentiation. These Th17 cells require B cells for sustained immunit...
https://www.cell.com/cancer-cell/fulltext/S1535-6108(25)00272-7
1
29
14
This announcement from the NIH is fantastic āNIH will no longer seek proposals exclusively for animal modelsā All new proposals should include modern alternatives: e.g. computational modeling and organoid style technologies with human components.
drugdiscoverytrends.com/nih-announces-ā¦
8 months ago
0
2
0
reposted by
Kimberly Luddy
Parmvir K Bahia
8 months ago
A week away from the start of the
@smbmathbiology.bsky.social
meeting in
#Edmonton
so it seems like an apt time to share my convo with conference organizer, Jay Newby. You'll also hear me nerding out about potassium channels in neurons š§
smb.org/news/13516785
#SciencePodcast
#BiologyInNumbers
loading . . .
0
4
4
reposted by
Kimberly Luddy
Nature Reviews Drug Discovery
8 months ago
Metabolites as agents and targets for cancer immunotherapy
www.nature.com/articles/s41...
rdcu.be/etLMD
This new Review discusses the role of metabolic pathways in cancer and immune cells in shaping the tumour microenvironment, and how they can be targeted to improve anticancer immune responses
loading . . .
Metabolites as agents and targets for cancer immunotherapyĀ - Nature Reviews Drug Discovery
Tumour cells undergo profound changes in their metabolism, but targeting these metabolic pathways requires understanding of the impact on immune cells as well as cancer cells. This Review discusses ho...
https://www.nature.com/articles/s41573-025-01227-z
2
12
4
reposted by
Kimberly Luddy
British Society for Immunology
8 months ago
š„ Dive into the latest on inflammasomes, innate immunity & more at our event with the BSI
#Inflammation
Affinity Group on 11ā12 Sept in Manchester! Cutting-edge talks, career workshops & networking with experts. Abstract deadline: 15 July! āļø Submit your abstract & register:
bit.ly/43q9x9r
0
2
1
Sarah Amend: Describing endocyling in cancer dormancy starts by highlighting the lethality of metastatic + therapy resistant cancer cells.
10 months ago
0
2
0
Guido Ferlazzo: Hepatic stellate cells facilitate the regrowth of dormant cancer cells by reducing NK cell regulation of dormancy in the liver.
10 months ago
0
0
0
Kenneth Pienta: Detecting prostate cancer metastasis with PSMA has changed his understanding of the metastatic cascade.
10 months ago
0
0
0
Day 2 of Cancer Dormancy and Therapy Resistance workshop.
10 months ago
0
0
0
Alessandra Riggio, discussing a rapid autopsy program in metastatic breast cancer. Finding disseminated cells undetectable by imaging.
10 months ago
0
1
0
Simone Baldassarri: Mathematical aspects of Dormancy for non experts. Dormancy and migration slow gentic drift and enhance diversity
10 months ago
1
0
0
Ann Zeuner asks, is Cancer Dormancy a Trojan horse or an Achille's heel?
10 months ago
0
1
0
Looking forward to a great conference on Cancer Dormancy and Therapy Resistance.
10 months ago
1
0
0
reposted by
Kimberly Luddy
Trends in Immunology
about 1 year ago
Helper ILCs in the human hematopoietic system
#immunology
loading . . .
Helper ILCs in the human hematopoietic system
Helper innate lymphoid cells (ILCs), comprising groups ILC1, ILC2, and ILC3, possess unique advantages in eliciting rapid immune responses and were recently found to exhibit direct tumor-killing capacities comparable with those of cytotoxic ILCs [naturalā¦
http://dlvr.it/TJBQG0
0
1
2
reposted by
Kimberly Luddy
Mary Canavan
about 1 year ago
Absolutely delighted to receive this award from
@researchireland.bsky.social
as Highly Commended in the Early Career Researcher of the Year 2024! I'm so grateful to all of my colleagues &the wider research community for their support. Looking forward to continuing our research in 2025 & beyond!
1
9
1
An important reminder: Science is really difficult. It's almost a daily conversation in the lab. Remember, 50% of what we do has never been done before. From the simplest experiments to the most indepth review. This stuff is not easy. Be kind and celebrate the wins!
about 1 year ago
0
3
0
Today's Integrated Mathematical Oncology research in progess talk, Thomas Veith: Optimizing the Replicator Equation to Model Frequency Dependent Effects in cancer, when Selection favors the rare phenotype.
#Oncology
about 1 year ago
1
3
0
reposted by
Kimberly Luddy
Adam Pennycuick
about 1 year ago
"Liquid biopsies" detecting ctDNA have a lot of promise but have had poor sensitivity in early stage disease. Can new ultra-sensitive techniques overcome these challenges? Impressive data from the TRACERx team
https://buff.ly/4jfMyF6
Found with
researchbriefing.com
loading . . .
Ultrasensitive ctDNA detection for preoperative disease stratification in early-stage lung adenocarcinoma - Nature Medicine
In the TRACERx cohort of 171 patients with lung cancer, the ultrasensitive detection of ctDNA improves preoperative patient stratification, also in early-stage disease.
https://www.nature.com/articles/s41591-024-03216-y
0
6
2
reposted by
Kimberly Luddy
Adrian Liston
about 1 year ago
The single best career advice that I give PhDs is that there are multiple different pathways to success. It is the detours that make your insights unique. This is why
@immunolcellbiol.bsky.social
made
#PathwaysToSuccess
- get inspired from different journeys!
onlinelibrary.wiley.com/page/journal...
loading . . .
<em>Immunology & Cell Biology</em> | ASI Journal | Wiley Online Library
<em>Immunology & Cell Biology</em> Ā is the flagship journal of the ASI, focusing on the general functioning of the immune system, with particular emphasis on its cell biology.
https://onlinelibrary.wiley.com/page/journal/14401711/pathways
1
60
27
reposted by
Kimberly Luddy
Marc Veldhoen
about 1 year ago
Precursors of exhausted T cells are preemptively formed in acute infection At that stage early precursors show diversity; memory T cells but also cells with a phenotype, gene-expression, and epigenetic profile that resembles precursors of exhausted T cells. #ImmunoSky
www.nature.com/artic...
#ImmunoSky
1/3
loading . . .
Precursors of exhausted T cells are preemptively formed in acute infection | Nature
T cell exhaustion limits effector T cell function in chronic infection and tumors1,2. The development of these hypofunctional T cells and of their precursors was considered to require stimulatory conditions met only upon persisting exposure to antigen and inflammation. In sharp contrast, we found similar T cell populations in the early phase of acute infections1,2. At that stage early developing TCF1+ precursor population shows an unexpected diversity, which includes precursors of normal memory T cells but also cells with a phenotype, gene-expression, and epigenetic profile that resembles precursors of exhausted T cells found in chronic infections. We demonstrate that high ligand affinity promotes, and PD-1 signaling restricts the development of these precursors. While these exhausted precursors are initially frequently found, they decline without being completely lost in infections the immune system resolves. We therefore concluded that precursor T cells with at least two distinct phenotypes are preemptively generated irrespectively of the outcome of the infection.
https://www.nature.com/articles/s41586-024-08451-4
1
33
9
reposted by
Kimberly Luddy
about 1 year ago
Interdisciplinary research is hard and I think interdisciplinary grants is the hardest
0
2
1
reposted by
Kimberly Luddy
Jalees Rehman
about 1 year ago
RNA sensing induced by chromosome missegregation augments anti-tumor immunity
www.cell.com/molecular-ce...
loading . . .
RNA sensing induced by chromosome missegregation augments anti-tumor immunity
Sasaki etĀ al. demonstrate that chromosome missegregation induced by SAC inhibition results in cytoplasmic dsRNA accumulation, primarily generated from non-exonic regions in the MNs. Activation of MAVS-mediated dsRNA sensing cooperates with dsDNA sensing to promote anti-tumor immunity.
https://www.cell.com/molecular-cell/fulltext/S1097-2765(24)00950-X
0
19
5
reposted by
Kimberly Luddy
Lydia Lynch
about 1 year ago
Delighted to share our paper on adipose gd T cells making IL-17 every night for homeostasis, coordinating lipid metabolism after eating
@natureportfolio.bsky.social
Huge effort by whole team and collaborators to work this out.
www.nature.com/articles/s41...
loading . . .
Article Metrics - Rhythmic IL-17 production by γΓ T cells maintains adipose de novo lipogenesis | Nature
https://www.nature.com/articles/s41586-024-08131-3/metrics
2
64
24
Merck shutters TIGIT and LAG-3 programs
firstwordpharma.com/story/5921957
We need more innovation. Immunotherapy is more than simple checkpoint blockade or specific antibody targets
#oncology
#immunology
loading . . .
FirstWord
https://firstwordpharma.com/story/5921957
about 1 year ago
0
0
0
Moffitt is hosting a full day retreat on AI in Cancer Careers. Coding, writing, and patient care. First take home - always disclose.
about 1 year ago
0
1
0
reposted by
Kimberly Luddy
Adam Pennycuick
over 1 year ago
ctDNA isn't great at detecting small, early stage cancers which don't shed much DNA. Could the systemic anti-cancer immune response be used for early detection? Interesting data here from colorectal cancer Paper found with
researchbriefing.com
.
loading . . .
Human blood cell transcriptomics unveils dynamic systemic immune modulation along colorectal cancer progression
Background Colorectal cancer (CRC) is the second leading cause of cancer-related deaths worldwide. CRC deaths can be reduced with prevention and early diagnosis. Circulating tumor DNA-based liquidā¦
https://buff.ly/3ATQGJC
0
8
3
reposted by
Kimberly Luddy
Thiago Carvalho
over 1 year ago
Every once in a while someone notices! 'The T cell response to cancer controls disease progression and response to
#immunotherapy
. Despite extensive knowledge regarding CD8 T cells, how CD4 T cells contribute to this process is less well understood.'
#immunology
loading . . .
Differentiation fate of a stem-like CD4 T cell controls immunity to cancer - Nature
A population of tumour-specific PD1+TCF1+ CD4 T cells in tumour-draining lymph nodes is capable of self-renewal and differentiation into CD4 effector cells, thereby controlling CD8 T cell activity.
https://www.nature.com/articles/s41586-024-08076-7
0
17
6
you reached the end!!
feeds!
log in